Stay updated on Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T10:55:48.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-20T01:57:42.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant revision.
    Difference
    0.2%
    Check dated 2025-01-12T22:35:06.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T23:14:31.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.
    Difference
    2%
    Check dated 2024-12-07T18:57:36.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The website has added new features while removing extensive options for downloading study data, including various file formats and detailed data fields.
    Difference
    4%
    Check dated 2024-11-23T05:34:24.000Z thumbnail image

Stay in the know with updates to Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial page.